Latest news with #Sozo
7NEWS
4 days ago
- Health
- 7NEWS
Best-selling under $40 hair mask saving Aussie strands this winter
Let's be real, winter is brutal on your hair. Between icy winds, overheated rooms, and constant styling, your strands are likely crying out for help. Dryness, split ends, flaky scalp and frizz seem to hit all at once, turning your once-shiny hair into a bit of a sad situation. But one Aussie-made product is getting glowing reviews for changing the game and giving salon-worthy results from your own shower. Meet the Sozo Hair Health Mask, a rich, nourishing weekly treatment that's taking over bathroom shelves across the country. It costs $39.95 and promises noticeable results in minutes. One happy customer shared, 'My curls are defined and zero frizziness, almost instant results. This is the only product I have tried that actually works.' So, what's in it? And why is it getting rave reviews? Packed with powerful natural ingredients, the Sozo Hair Health Mask is all about natural nourishment. No silicones, no harsh chemicals, just a carefully crafted formula of ingredients your scalp and hair will actually recognise. Here's what you'll find inside: Manuka honey to soothe irritation and boost hydration Jojoba oil and sunflower seed oil for deep moisture Beetroot extract and argan oil to strengthen damaged hair Coconut oil for a summery scent and added softness Aloe vera, hyaluronic acid and native botanicals to calm the scalp and add shine It's a formula that goes deeper than your average hair treatment. While some masks coat the surface and give temporary smoothness, this one works on both your scalp and strands to restore long-term health. A winter essential for every hair type The thick and creamy texture of this mask makes it feel luxe without leaving hair limp or greasy. It suits all hair types, from curly and coarse to fine and thinning, and helps tackle winter issues like dryness, static, flaking and split ends. Use it once a week in place of your usual conditioner. Let it sit for five minutes while you're in the shower, or leave it on for up to thirty minutes for a more intense treatment. 'My hairdresser has noticed a vast improvement in my hair health. Smells amazing too,' one customer said. 'Best hair mask. My hair is always shiny and feels soft. Highly recommended,' a second review shared. 'I have fine thinning hair, and my hair feels and looks thicker since using Sozo,' a third shopper wrote. Why it's a winter must-have During the colder months, moisture is stripped from your hair and scalp thanks to indoor heating, cooler air, and the extra styling many of us do to tame flyaways. Hair becomes more fragile and prone to damage, and scalps often end up dry, flaky and itchy. Adding Sozo's Hair Health Mask to your weekly routine is one of the easiest ways to fight back. It hydrates and repairs, boosts shine and softness, and helps soothe your scalp. The coconut oil scent makes every wash feel like a mini holiday. It's also made right here in Australia and is cruelty-free, so you know exactly what you're putting on your hair. Not just hype With hundreds of 5-star reviews and loyal customers who've made it part of their routine, the Sozo Hair Health Mask is more than just a pretty tub on your bathroom shelf. It's a practical product that delivers real results. It's available on its own for $39.95, or you can bundle it up with the Hair Health Trio (which includes the shampoo, conditioner and mask) for $99.95.
News.com.au
30-04-2025
- Business
- News.com.au
Health Check: Impedimed says ‘nuts' to tariffs as it squirrels away components
By stockpiling components, the US-focused Impedimed is taking no chances with tariffs Cashed-up Amplia forges ahead with promising pancreatic cancer trial Some biotechs are headed to the well, while others are rolling in the green stuff The maker of Sozo lymphoedema measurement devices, ImpediMed (ASX:IPD) says it will spend $1.2 million to stockpile foreign componentry in the US. CEO Parmjot Bains today said the items would be bought at 'pre-tariff prices to further reduce the risk of disruption.' Earlier this month Impedimed said it expected 'no material impact' from tariffs, given its Sozos are made in the US from 'substantial US componentry'. But the squirrelling of parts – mainly electronic components ultimately sourced from Asian countries including Taiwan and Malaysia – highlights the measures US exposed device and drug makers are taking to avoid any collateral damage. The Trump administration has plonked a 32% tariff on Taiwan – the world's computer chip capital – although the impost is on pause and open for negotiation with the Great Dealmaker. Impedimed, meanwhile, has pledged to rev up its US sales. This is despite posting record March quarter revenue of $3.4 million, 31% higher year on year. The company sold 36 Sozo units, 22 in the US. "While there's a lot to like in the result … we still need to see a significant acceleration in US sales," Bains said. And sales teams take note: she expects improved US turnover for the rest of the calendar year. After burning $3.5 million during the quarter, Impedimed had a lush $27.8 million cash balance. This includes a US$10 million drawdown on a US$15 million loan facility. Hitherto assessed with a tape measure, lymphoedema is the swelling of limbs because of cancer treatment. Amplia advances pancreatic cancer trial Amplia (ASX:ATX) today said it had $10.9 million in its kitty after expending $2.7 million during the quarter. This makes management even more confident of completing its encouraging local pancreatic cancer trial. Dubbed Accent, the 55-patient phase IIa trial tests Amplia's narmafotinib (AMP-945) alongside the standard-of-care chemotherapy (gemcitabine). In an update on Monday, the company said of the 29 advanced pancreatic cancer patients assessed to date, 11 had a partial response. This means they had a tumour shrinkage of 30% or more, sustained for at last two months. This response rate of 38% compares with the historical average of 23% for chemo alone. The results also show the patients remained on the trial for a median 208 days, compared with 117 days for the chemo-alone group. 'That's probably the most important data, because we expect that will translate into progression-free survival (PFS) data and ultimately overall survival (OS).' says Amplia CEO Dr Chris Burns. Burns, by the way, co-invented the US-approved myelofibrosis drug Ojjaara. PFS is the length of time a patient lives with a disease without the disease getting worse. OS is the length of time from diagnosis or treatment until death, regardless of the cause of death. 'That's what you care about as a patient: how long am I able to take these drugs to stop the disease progressing," Burns says. The company expects a read-out on PFS data in the September quarter. Pancreatic cancer is one of the deadliest of all cancers, with an average nine months' life expectancy with the current chemotherapy. 'Commercially, while it is challenging you don't have to do a lot for it to be meaningful,' Burns says. Time to rattle the can … With today marking the cut-off for March quarter reports, lodgements are flooding in like Wivenhoe Dam after one of these one-in-100-year floods that happen every couple of years. While there's plenty of cheer, some biotechs clearly need cash if they are to remain viable. A developer of natural pesticides and insecticides, Bio-Gene Technology (ASX:BGT) had cash burn of $644,000 and no revenue, reducing its cash to $683,000. 'A capital raising is imminent and the company believes these activities will be successful in raising cash,' the company says. Bio-Gene also has US$3 million in grants across two US military programs, including a push to banish bed bugs (an itchy problem in those shared dorms). Opyl (ASX:OPL) late yesterday reported receipts of $2000 and burn of $262,000, taking its cash to a mere $64,000. The company also has $380,000 of drawn loans and $25,000 of loan headroom. Today, Opyl shares entered trading halt as the company was 'considering, planning and executing a capital raising'. Opyl is interesting, having developed an algorithmic tool to predict the outcome of clinical trials (and to run them optimally). The developer of blood and glucose tests and quality control assays for winemakers, Universal Biosensors (ASX:UBI) upped receipts by 28%, to $1.6 million. But the company's burn of $3.7 million reduced cash to $4.9 million. Universal is having capital raising discussions with 'various interested stakeholders' and the 'likelihood of success is high'. Device innovator Hydrix (ASX:HYD) has a lot of groundbreaking projects. But with its cash whittled down to $289,000, short-term survival is the key and management is taking action including chasing tardy debtors. … while others are rolling in cash Mesoblast (ASX:MSB) burnt through US$12.7 million but has a handy US$182 million in the bank as it commercialises its now US-approved treatment for paediatric graft-versus-host disease. Genetic Signatures (ASX:GSS) is also strongly positioned, with $37.4 million of cash, having burnt a modest $300,000 in the quarter. Genetic also posted $2.9 million of sales, up 71%. As with Mesoblast, the company is in the early stages of US commercialisation, for its recently approved gastrointestinal bug test Easyscreen. Percheron Therapeutics (ASX:PER) burnt $4.47 million during the quarter and ended up with $12.9 million of cash. The dosh is the residue of a capital raising to support Percheron's now-abandoned Duchenne muscular dystrophy program. Having survived a second board spill last week, management is scouring for an alternative asset to deploy the residual spendoolies. Orthocell (ASX:OCC) earlier reported a generous cash balance of $31.7 million. That's more than enough to support Orthocell's product commercialisation including the rollout of its Remplir nerve repair device in the US. But the stock spiked up to 13% this morning for a different reason: Canada – a.k.a. the 51 st state – has also approved Remplir.
7NEWS
29-04-2025
- Lifestyle
- 7NEWS
Aussies favourite natural hair growth brand is offering the chance to win more than $400 worth of products
Having healthy, full hair gives you the biggest confidence boost and if you're sick of battling dry, brittle locks then you're going to love this Aussie haircare solution. Aussie all-natural hair growth brand, Sozo Australia is known for creating thousands of Aussies hair transformations. What sets Sozo Australia apart is its science-backed, all-natural approach to haircare. Every product is free from harsh chemicals, including sulphates, silicones, parabens, and artificial fragrances. Instead, formulas are infused with aloe vera as the first ingredient, rather than water, to deeply hydrate and nourish the scalp and hair. Other potent botanicals like green tea and lavender oil are carefully selected to soothe the scalp, reduce inflammation, support hair growth, and boost shine — naturally. Best yet, you can win your way to incredible hair thanks to Sozo's latest giveaway. Intrigued? Keep scrolling to find out how to enter. Epic giveaway From 5pm today until 5pm on May 5, Sozo Australia is not only offering 15 per cent off sitewide, shoppers can use code 'MUM15' at checkout to take advantage of this limited-time deal. Sozo Australia is also giving you the chance to win a Mother's Day giveaway worth more than $400. One lucky winner will receive two Complete Scalp & Haircare Bundles — one to enjoy themselves and one to gift to a deserving mum or loved one. Each beautifully gift-wrapped bundle includes Sozo's best-selling Shampoo, Conditioner, Hair Mask, Scalp & Hair Health Serum, a Bamboo Microfibre Hair Towel, and a Detangling Brush, crafted to deliver a complete, natural haircare routine. To enter, participants must sign up via the official giveaway page (live at the start of the giveaway), follow Sozo on Instagram, like the giveaway post, and tag a special person they'd like to share the bundle with — or comment on why they want to gift a loved one a hair transformation. For additional entries, customers can place an order while the giveaway is live. Sozo Australia was founded by Isabella Charanduk, from the Gold Coast, after she struggled with hair loss following a type 1 diabetes diagnosis. This is what became the catalyst for Isabella creating Sozo, as she noticed so many haircare products available on the market were filled with chemicals, despite labels stating they were made from all-natural ingredients. These products are designed to cleanse the hair effectively without stripping or drying it out, ensuring that it remains soft and healthy. The ingredients also work to soothe the scalp and reduce inflammation, providing comfort and care to sensitive skin. Incredible transformations Sozo Australia's formulations strengthen the hair, reducing breakage and promoting resilience, while increasing shine and improving the overall appearance of the hair. Additionally, the haircare line helps to combat the effects of ageing, offering protection against UV damage. They also smooth and reduce frizz, leaving the hair with a sleek and polished finish. . Shoppers are loving their results after using Sozo haircare and have given the products a 5-star rating on Sozo Australia's website. 'Absolutely love the shampoo and conditioner. I have always had sensitive skin and get bad dandruff from every other hair product I've tried except for these ones,' one person wrote. 'These products are amazing, My hair is now always shiny and feels soft. Highly recommended,' a second reviewer added. 'My hair is thin and fine. This is the best hair system I have found so far,' a third customer wrote.
